I spoke with Igor last night after the meeting, but I did
I spoke with Igor last night after the meeting, but I did not attend (for personal reasons unrelated to Baltia).
We didn't review my most important next step - promoting the company - but it wasn't the right time to talk about that anyway. Let the man celebrate his victory. He's been at this for well over half of his adult life.
At any rate, I heard proving flights in "5 to 6 weeks" from a fellow investor, but a few days before the meeting I was informed to get my financing together by the very end of October/very beginning of November (which in my mind is more like 3 to 4 weeks).
I don't know, but does all this mean that we could actually be certified by Thanksgiving (if they are pushing for first revenue flight by the 3rd week of December?).
I've been told that during all the unforeseen delays as of late, that Baltia was actually addressing some of the things in Phase III - so in theory you might believe that Phase III is going to go very quickly (again, as I have been told).
Then again.....this is Baltia....and I have NEVER seen them hit a Projected Target Date - EVER!
Still..........even though it takes longer than anyone wants it to, it still moves foward (like lava?).
I'm curious now about the video of N706BL arriving at JFK, ticket sales and advertising, promoting the company,.....and most importantly....what all this will mean to the pps.
GLTA.
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Albion Enterprise VCT PLC Enhances Its Equity Portfolio Albion Enterprise VCT PLC (LSE: AAEV) has recently made a significant move to bolster its equity by issuing new shares. This decision aligns with the company’s commitment to expanding its capital while providing opportunities for shareholders through its Dividend Reinvestment Scheme. Details of the New Share...
Continue Reading
Capsida's Recent Advances in Genetic Medicine Capsida Biotherapeutics has made a remarkable stride by partnering with AbbVie to combat neurodegenerative diseases, a step that marks a significant achievement in the realm of genetic medicine. The collaboration has evolved, leading to AbbVie exercising its option on the first neurodegenerative disease program, which...
Continue Reading
AB Amber Grid's 2024 Operating Results Overview AB Amber Grid has published its unaudited financial results for the year 2024, reflecting the company’s performance in accordance with the International Financial Reporting Standards. With a focus on strategic growth, the company demonstrated robust management despite challenges in the market. Financial Performance...
Continue Reading
Linkage Global Inc. Closes $1 Million Private Placement Financing Linkage Global Inc (NASDAQ: LGCB), a leading cross-border e-commerce service provider based in Japan, has successfully completed a private placement financing that raised $1 million. This announcement marks a significant milestone for the company as it continues to enhance its financial foundation. Details...
Continue Reading
Understanding the Amedisys and UnitedHealth Merger Situation Amedisys Inc (NASDAQ: AMED) has seen its shares rise as the company announces an extension to its merger deadline with UnitedHealth Group Incorporated (NYSE: UNH). This unexpected turn of events has grabbed the attention of investors and industry watchers alike. What Is the Merger About? The proposed merger...
Continue Reading